Please login to the form below

Not currently logged in
Email:
Password:

Polyphor appoints new chief medical and development officer

Dr Debra Baker joins the firm from Novartis

Polyphor has appointed Debra Baker as its new chief medical and development officer (CMDO) in a role that focuses on clinical strategy and drug development.

Dr Baker arrives at Polyphor from Novartis, where she held several positions including global head of medical affairs, development head for infectious diseases, transplants and immunology, and global head of clinical operations and services.

She said: “it is an exciting time to join Polyphor and I am very eager to share my experience in drug development in its mission to help patients.”

Giacomo Di Nepi, CEO at Polyphor, added: “I am very happy Debra joins Polyphor. I had the opportunity of working with her at Novartis and really appreciated her leadership, drive and capabilities. Her expertise is immediately applicable to her new role as CMDO of Polyphor and to our clinical programmes,”

Dr Baker succeeds Leon Hootftman, who leaves Polyphor to take a new position.

17th March 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics